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Elenine is the aglycone of elenoside, a cytotoxic arylnaphthalene lignan (NSC 644013-W/1) derived from Justicia hyssopifolia.
(Family: Acanthaceae). Elenoside is a β-D-glucoside, with a similar chemical structure to etoposide, exhibiting central depressant
activity. In the present study, elenine was given to mice and rats at doses of 10, 20, and 40mg/kg. Acute toxicity (24h) and general
behaviour in mice was studied as well as its eﬀects on muscular relaxant activity, locomotor activity (Varimex test), and the
open-ﬁeld test and were compared with 10mg/kg of chlorpromazine. Elenine produced a reduction in the permanence time
in muscular relaxant activity (traction test). Spontaneous activity was lower in the Varimex test. The ambulationand rearing were
lower compared with the control group, and an increase in boluses was observed in the open-ﬁeld test. Thus, it can be concluded
that elenine has central sedative eﬀects at lower doses than those used with elenoside and has a possible application in conditions
of anxiety.
1.Introduction
Justicia hyssopifolia, in the Canary Islands, is believed to have
laxative, purgative, anticarcinogenic as well as antiviral, and
insecticidal properties [1, 2]. A large number of arylnaph-
thalene lignans have been isolated from diﬀerent species of
Justicia, many of them exhibiting diverse biological activities
of which the most noteworthy are their antitumoral, insec-
ticidal, cardiotonic, analgesic, inhibitor of lipid peroxidation
and anti-inﬂammatory properties. Activities of interest also
include its action on the central nervous system. The lignans
arecapableofactingbothasdepressantsandantidepressants.
Thus, (+)-nortrachelogenin causes depression in rabbits [3],
and prostalandins A, B and C produce a mild depression in
rats and mice [4]. Bisepoxylignan glycoside simplexoside has
CNS-depressant activity in mice and rats while the genin is a
stimulant [5].
It is well known that etoposide and other podophyllo-
toxin derivatives, used for their antineoplastic or antimitotic
eﬀects, aﬀect the nervous and gastrointestinal systems.
Therefore, central eﬀects are delayed in onset and prolonged
after onset and include acute psychotic reactions, halluci-
nations, confusion, dizziness, stupor, ataxia, hypotonicity,
seizures, and coma. Peripheral and autonomic neuropathies
develop later and may result in paresthesia, reduced reﬂexes,
muscle weakness, and acute dystonic reaction [6, 7]. Gas-
trointestinal disorders may be more common after oral
administration [8].
In a previous research [9], we reported the isolation
of an arylnaphthalene lignan named J2 and its aglycone J1
from Justicia hyssopifolia and which we called elenoside and
elenine, respectively, the ﬁrst as a β-D-glucoside. Elenoside
(NSC644013-W/1)displayedcytotoxicactivitywhenstudied
by the human tumour cell line panel of the US National
Cancer Institute (NCI) [10]. Elenoside is a lignan with an
action similar to that of purgative and prokinetics drugs
and could be an alternative to cisapride in the treatment
of gastrointestinal diseases as well as a preventive therapy
for the undesirable gastrointestinal eﬀects produced by
opioids used for mild to moderate pain [11]. Furthermore,
elenoside showed a decrease in the parameters of general
observable behaviour evaluated by behavioural, neurolog-
ical, autonomic and toxic reactions [12, 13]. Elenoside
showed depressant central nervous activity at doses 25 and
50mg/Kg [14]. In the present research, general observable
behaviour and the CNS-depressant activity of elenine at
doses of 10, 20, and 40mg/Kg was studied. Elenine has
central sedative eﬀects at lower doses than those used with2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Elenine.
elenoside and has a possible application in conditions of
anxiety.
2.MaterialandMethods
2.1. Chemicals and Treatment. Elenine (3-hidroxy-metyl-
1-methoxy-5,6-methylene-dioxy-4-(3,4-methylenedioxyph-
enyl)-2-naftoic acid lactone) (Figure 1) was obtained as
described and its purity was established on the basis of the
spectra (1H, 13CNMR, and mass) data [9].
Elenine was dissolved in a mixture of propyleneglycol-
ethanol-Tween 80 (40:10:50) and administered intraperi-
toneally at doses of 10, 20, and 40mg/kg. The control group
only received the vehicle propylene glycol-ethanol-Tween
80 (40:10:50). Chlorpromazine hydrochloride (Rhone-
Poulenc), 10mg/kg i.p. with the same vehicle, was used.
Drugs were injected into animals i.p. 1h before testing.
2.2. Animals. Swiss albino male mice (weighing 30–40g)
and Sprague-Dawley male rats (weighing 200 to 250g) were
used. The animals were housed under normal laboratory
conditionsat22◦Conastandardlight-dark schedule(12:12;
lights on: 0800 to 2000) and were given free access to
standard laboratory diet and water. The animals were
habituated to the testing apparatus, on several occasions
for periods of two hours, on 2 consecutive days before real
Varimex or open-ﬁeld testing. Habituation was carried out
in the absence of drug eﬀects. Hypothermia in mice was
observed in a subjective manner (by manual touch). This is
the reason why (+) is used as the score in the Irwin test. The
animals were assigned to randomised groups of 10 animals
each. Animal care complied with the Guide for the Care and
Use of Laboratory Animals. The study plan was approved by
the local ethical committee for animal experimentation of
University of La Laguna.
2.3. Toxicity of Elenine and LD50 Determination. A total of
60 male mice (30–40g) were allotted to the diﬀerent control
and test groups. The control group received the vehicle, and
the test groups received doses of 150, 176, 207, 244, 287
and 338mg/kg of elenine. The animals were kept in plastic
cages (10 animals per cage), and mortality, physiological
and behavioural signs of toxicity, such as motor activity,
ataxia, ventral reclining, respiratory distress, hypothermia,
piloerection,and palpebralclosure,were notedbeforedosing
and 0.5, 1, 2, 4, 6, 12, 24 h after dosing every day for a 7-day
period [13]. The LD50 24h of elenine was calculated using
the Spearman-K¨ arber method [15].
2.4. General Behaviour: Irwin Test. The Irwin test is a
systematic observational procedure for assessing and scoring
theeﬀectsofdrugsonthebehaviouralandphysiologicalstate
of rodents. The method is part of the safety pharmacology
core battery recommended by International Committee for
Harmonization to detect potential adverse eﬀects of candi-
dates on the central nervous system (CNS) before human
testing. When applied at an early stage of drug development,
this test is particularly suitable to (a) screen and select
compounds against unwanted CNS eﬀects, (b) understand
the mechanism underling these eﬀects, (c) help improve the
structure-activity relationship, and (d) possibly, reveal novel
therapeutic eﬀects. By using an appropriate dose range for
each test molecule, it is possible to obtain information on its
pharmacological proﬁle, on the intensity and the duration of
its eﬀects, and on the speciﬁcity of these eﬀects. We used the
original Irwin test with minor modiﬁcations. Mice (30–40g)
receive the test compound by intraperitoneal route and are
observedat30,60,120and180minutesafteradministration.
At each observation time, 25 parameters are scored using a
rigorous standardized procedure based on the one described
by Irwin. These parameters are distributed as follows: 9
items for the behavioural proﬁle (body position, locomotor
activity, transfer arousal, touch escape, positional passivity,
toe pinch, corneal, pinna, and tail elevation); 10 items
for the neurological proﬁle (body tone, abdominal tone,
limb tone, grip strength, wire manoeuvre, righting reﬂects,
hypotonic gait, tremors, twitches, and convulsions); 6 items
for the autonomic proﬁle (palpebral closure, diarrhoea,
piloerection, hypothermia, respiratory rate, and skin colour)
[16].
This test was performed with fourty male mice (30–40g)
that were assigned to four randomized groups of 10 animals
each. The groups were observed at 30, 60, 120, and 180min.
following the intraperitoneal administration of the vehicle,
10, 20, and 40mg/kg of elenine.
2.5. Lim Test. The measurements of the animal behaviour
were also determined as described by Lim [17], with minor
modiﬁcations. Three parameters are scored: muscle tone
or the amount of tension or resistance to movements in
a muscle, spontaneous movements or activity produced
or performed through natural processes without external
inﬂuence, righting reﬂex or the ability to assume an optimal
position when there has been a departure from it. This
test was performed using 40 male mice (30–40g) that were
assigned to four randomized groups of 10 animals each. The
groups were observed before and for 1, 2, and 3 hours after
administration of the vehicle, with 10, 20, and 40mg/kg ofEvidence-Based Complementary and Alternative Medicine 3
elenine. The mice were evaluated for loss of spontaneous
movements, loss of muscular tone and loss of righting
reﬂex.
2.6. Physiological or Behavioural Changes Following a 7-Day
Daily Treatment. Fourty male mice (30–40g) were assigned
to four randomized groups of 10 animals each. The groups
were observed at 30, 60, 120, 180, and 240min following
intraperitoneal administration of the vehicle, with 10, 20,
and 40mg/kg of elenine every day for a 7-day period. The
animals were kept in plastic cages (10 animals per cage).
Changes in neurological, autonomic, and toxic reactions and
behaviour were noted.
2.7. Muscular Relaxant Activity (Traction Test). The exper-
iment was performed using 50 male mice (30–40g) that
were assigned to four randomised groups of 10 animals each
receiving the vehicle, with 10, 20, and 40mg/kg of elenine or
chlorpromazine, 10mg/kg i.p. The forepaws of each mouse
were placed in a small twisted wire rigidly supported above a
benchtop.Normalmicegraspedthewire with theirforepaws
and, when theywere allowed to hang free, theyplaced atleast
one hind foot on the wire within 5 seconds. Inability to place
at least one hind foot was considered a failure to traction
[18].
2.8. Locomotor Activity (Varimex Test). T h en a m eV a r i m e x
suggests this is an instrument capable of measuring a variety
of movements. Motor activity was measured in an activity
meter (Varimex, Columbus Instruments), provided with
horizontal electromagnetic sensors, which consisted of two
standard plastic rat cages lined with a layer of ground corn
cob bedding. When inductive horizontal sensors are used,
Varimex can be used in the same way as the two alternative
working activity meters which can operate either in normal
mode or selective mode.
The inductive sensor is composed of six inductive
coils connected in series and tuned to resonance with an
additional internal capacitor. When an animal approaches
one of the coils, the voltage signal is subsequently ampliﬁed
and recorded by the Varimex counter. Normal operation is
characterized by a high operating frequency, of resonance
circuit which results in higher sensitivity for movements of
animal bodies.
In selective operation, the sensor operates at a relativity
lower frequency so that the animals’ body does not generate
strong enough signals to be recorded. Only when an animal
moves (which couples well with the magnetic ﬁeld induced
by the sensor) does the animal movement result in a
measurable pulse. On this basis, animals marked by metal
loops can be selectively monitored, while animals without
the metal loops are not visible to sensor. The best sensitivity
of Varimex in selective mode is obtained when the plane
of the coil (loop) attached to the animal is parallel to
sensor coils, that is, horizontal plane. The animals were
habituated, on several occasions for periods of two hours,
to the testing apparatus before real testing on 2 consecutive
days. Habituation was carried out in the absence of drug
eﬀect. The following day, according to Tyler and Tessel, one
animal was placed in each cage for 1 hour, but the activity
was only recorded for the second half-hour. Thus, initial
locomotoractivitywasnotmeasured[19].Groupsof10male
rats received vehicle, with 10, 20, and 40mg/kg of elenine or
chlorpromazine, 10mg/kg i.p. A total of 50 male rats (200–
250g) were distributed among the diﬀerent control and test
groups.
2.9. Open-Field Test. The open-ﬁeld test has been used as
an animal model of emotional behaviour. Animals with
higher levels of motor activity, and lower boli rates have
been taken to indicate that they exhibit less emotionality
(anxiety, fearfulness). Some authors suggest that the open-
ﬁeld test shows aspects of many types of behaviour including
exploration, locomotor activity and anxiety. The animals
were habituated, on several occasions for periods of two
hours, to the apparatus for open-ﬁeld testing on two
consecutive days before testing. Habituation was carried out
in the absence of drug eﬀect. In the open-ﬁeld test, which
was performed on the following day, one animal was placed
in the open-ﬁeld apparatus for 5min, but the activity was
only recorded for the following 5min.
The open-ﬁeld apparatus consisted of a circular ﬁeld of a
76cm diameter and a nontransparent white wall 55cm high.
The ﬂoor was marked oﬀ into 17 sectors divided by two
circles into outer, inner, and central regions. A 60W light
bulb was hung above the centre of the open ﬁeld. Each rat
was individually placed into an external sector of the open
ﬁeld. The total number of sectors entered by the animal (at
least three quarters of the body), the number of rearing, and
the number of defecation boluses were recorded over a test
periodofﬁveminutes.Theﬂooroftheopenﬁeldwascleaned
with water when the animals were changed [20]. This test
was performed on ﬁve groups of 10 male rats (200–250g)
each and 10, 20, and 40mg/kg of elenine or 10mg/kg of
chlorpromazine in the vehicle were administered i.p.
2.10. Measurement of Blood Pressure. Blood pressure in
conscious rats was measured in an LE 5000 Digital Pressure
meter. The LE 5000 is an electronic instrument designed to
provide visual display and measurement of arterial pressure
(systolic and diastolic), and pulse rate in animals. This is
a system that is widely used to determine maximum and
minimum pressure; it functions by causing an artery to
collapse (sphyngomanometer), using pressure produced by
cuﬀ;bloodpulsesare pickedupbyanappropriatetransducer
unit.
The overall operation of the apparatus is as follows: an
internal pressure transducer with a high resolution feeds a
signal to an analogical/digital converter that is equivalent to
the air pressure that exists at each moment in the pneumatic
line (and, therefore, the one present in the cuﬀ). This
air pressure can be produced manually with a pear, or
automatically with a pressure cylinder. The analogical/digital
converter activates a three-digit display that provides a
readout of the value of successive pressures, expressed in
millimetres of mercury and with a resolution of 1mmHg.
Another transducer, this one external, records blood
pulses and transmits this information to the control circuit4 Evidence-Based Complementary and Alternative Medicine
which cuts oﬀ the display when it fails to receive a signal
due to the collapsing of an artery, and therefore the systolic
pressure (SP) is projected. When the pressure in the line
drops, the display again readsout values corresponding to
the pressure, until such time as the amplitude of the cardiac
pulsations regains 80% of their initial value; at this time, the
display is cut oﬀ again, and the value of diastolic pressure
(DP) can be read. The pulse rate is also shown on the display,
in beats per minute (from 1 to 999).
Pressure in rats is recorded in the tail and in the caudal
artery. Itisnecessary toimmobilizethem,using aholder,and
it is convenient to subject them to a vessel dilation process
beforehand, viaheat treatment, so thatarterial pulsations are
as clearly deﬁned as possible and free from interference from
other signals which are generally due to respiration, stress or
muscular tremors.
Fifteen male rats (200–250g) were assigned to three
randomized groups of ﬁve animals each. The blood pressure
was observed at 0, 30, 60, and 120 minutes following the
intraperitoneal administration of 10, 20, and 40mg/kg of
elenine.
2.11. Statistical Analysis. Testing out the homogeneity of
variance amonggroupswasperformed usingtheSPSSStatis-
tic Program. As a result, the Kruskal Wallis Test (ANOVA)
followed by the Mann-Whitney test were conducted for the
comparison between the mean study groups in the Varimex
a n dO p e nﬁ e l dt e s tu s i n gt h eP r i s mP r o g r a m .T h ec h i - s q u a r e
test was used for analyzing the results obtained in the Irwin
and the Lim test. Diﬀerences were considered signiﬁcant
when associated with a probability of 5% or less.
3.Results
3.1. Acute Toxicity. The LD50 (24h) of elenine in mice was
254mg/Kg by i.p. route. This result indirectly indicates the
a b s e n c eo fs e v e r et o x i ce ﬀects. Death was not induced in the
remainder of the animals during the following 7 days.
3.2. General Behaviour: Irwin Test. Elenine produced a
reduction of spontaneous activity, reﬂected by body position
and locomotor activity scores, which tend to decrease as a
function of time and dose (P<. 05 control versus 10, 20,
and 40mg/Kg elenine at 30, 60, 120, and 180min). There
was a decrease in the transfer arousal and touch escape
(P<. 05 control versus 10, 20, and 40mg/Kg elenine at
30, 60, 120, and 180min) and an increase of positional
passivity (P<. 05 control versus 10, 20, and 40mg/Kg
elenine at 30, 60, 120, and 180min) representing the motor
aﬀective response. The sensorimotor response, evaluated by
toe pinch (ipsilateral ﬂexor reﬂex), and corneal and pinna
reﬂex, revealed a reduction of the responses P<. 05 control
versus 10, 20, and 40mg/Kg elenine at 30, 60, 120, and
180min). The responses showed a reducedbehaviouralstate.
The neurological state was evaluated by muscle tone
(body, abdominal and limb tone, grip strength and wire
manoeuvre), equilibrium and gait (righting reﬂex and
hypotonic gait). Elenine produced a decrease in the muscle
tone, equilibrium and hypotonic gait responses (P<. 05
control versus 10, 20, and 40mg/Kg elenine at 30, 60, 120,
and 180min).
Nonobserved excitation was evaluated by phenomena
such as tremors, twitches and convulsions. Autonomic
measurements revealed a slight palpebral closure (P<. 05
control versus 10, 20, and 40mg/Kg elenine at 30, 60, 120,
and 180min). Diarrhoea and a decreased respiratory rate
were observed. The eﬀects of elenine on the behavioural and
physiological state (neurologic and autonomic) diminished
as a function of time and administered dose (Table 1).
3.3. Lim Test. Elenine was compared with a major tran-
quilizer (Chlorpromazine) on parameters aﬀected by this
tranquilizer, such as spontaneous movements, muscle tone
and righting reﬂex. Table 2 s h o w sa ni n c r e a s ei nt h en u m b e r
of animals with loss of spontaneous movement (P<
.05 control versus experimental groups) and muscle tone
(P<. 05 control versus experimental groups) at 1 and
2h, after administration of 10, 20 and 40mg/Kg of elenine
and 10mg/Kg of chlorpromazine. No statistical diﬀerences
between 2 and 3h after administration of 10, 20 and
40mg/Kg of elenine and 10mg/Kg of chlorpromazine were
observed. Loss of righting reﬂex at 1, 2, and 3h after
administration of 40mg/kg of elenine and 10mg/Kg of
chlorpromazine was observed.
3.4. Physiological or Behavioural Changes Following a 7-Day
Daily Treatment. An examination of the general pharma-
cological eﬀects of elenine observing changes in behaviour,
neurological, autonomic parameters a 7-day daily treatment
revealed that elenine, on the ﬁrst day, at doses of 10, 20
and 40mg/kg reduced spontaneousa c t i v i t y( b o d yp o s i t i o n ,
locomotor activity) as a function of time and dose (P<. 05
control versus 10, 20, and 40mg/kg elenine at 30, 60 120,
and 180min). At 240min a normal spontaneous activity
with respect to control was obtained. There was a decrease
in the motor aﬀective response (transfer arousal, touch
escape, positional passivity) (P<. 05 control versus 10,
20, and 40mg/kg elenine at 30, 60, 120, and 180min). At
240min a normal score respect to control was observed.
A dose-dependent reduction of sensory motor (toe pinch
corneal and pinna) was also observed (P<. 05 control
versus 10, 20, and 40mg/kg elenine at 30, 60, 120, and
180min). Elenine produced a decrease in muscular tone
(body tone, abdominal tone, limb tone and grip strength),
a loss and with equilibrium and hypotonic gait (P<. 05
control versus 10, 20, and 40mg/kg elenine at 30, 60, 120,
and 180min). No CNS excitation (i.e., tremors, twitches
and convulsions) was observed. The presence of palpebral
closure, hypothermia, reduction in respiratory rate and
the manifestation of diarrhoea indicates some autonomic
nervous system involvement.A normal score for these eﬀects
was obtainedat 240min. These itemswere evaluatedoverthe
following six days and no changes in parameters (behaviour,
neurological, and autonomic) were observed with respect to
the preceding day.
3.5. Muscular Relaxant Activity. Figure 2 shows the time that
animals remained clinging to the stainless steel wire at the 30Evidence-Based Complementary and Alternative Medicine 5
Table 1: General activity and time-dose response summary showing the average data score.
Time after drug (min)
30 60 120 180
Dose (mg/Kg)
a C 10 20 40 C 10 20 40 C 10 20 40 C 10 20 40
Behavioural
(1) Spontaneous activity
Body position 4 2.8∗ 2∗ 1.8∗ 42 . 6 ∗ 2.8∗ 1.6∗ 42 . 2 ∗ 1.8∗ 1.6∗ 42 . 2 ∗ 1.8∗ 1.6∗
Locomotor activity 4 3∗ 2∗ 1.8∗ 42 ∗ 1.6∗ 1.5∗ 42 ∗ 1.5∗ 1.5∗ 42 ∗ 1.5∗ 1.5∗
(2) Motor-aﬀective response
Transfer arousal 4 3.1∗ 2.5∗ 2.3∗ 42 . 7 ∗ 2.3∗ 2.2∗ 42 . 4 ∗ 2.2∗ 2.2∗ 43 ∗ 2∗ 2∗
Touch escape 4 3.6 ∗ 2.3∗ 2∗ 43 . 3 ∗ 2.3∗ 1.8∗ 43 ∗ 2∗ 1.8∗ 43 ∗ 2∗ 1.8∗
Positionalpassivity 0 0 2∗ 1.9∗ 40 2 ∗ 1.9∗ 40 2 ∗ 1.9∗ 40 2 ∗ 1.9∗
(3) Sensorimotor response
Toe pinch 4 3.2 ∗ 2∗ 2∗ 43 ∗ 2∗ 1.7∗ 43 ∗ 2∗ 1.7∗ 43 ∗ 2∗ 1.7∗
Corneal 4 3∗ 2.5∗ 2.5 4 3∗ 2.5∗ 2.5∗ 43 ∗ 2.5∗ 2.5∗ 43 ∗ 2.5∗ 2.5∗
Pinna 4 3.4 3.2∗ 2.8 4 3.4∗ 3.2∗ 2.8∗ 43 . 4 ∗ 3.2∗ 2.8∗ 43 . 4 ∗ 3.2∗ 2.8∗
(4) Posture
T a i l e l e v a t i o n 2 222 2 222 2 22 22 222
Neurologic
(1) Muscle tone
Body tone 4 3.5∗ 3.∗ 3∗ 43 . 2 ∗ 2.8∗ 2.6∗ 43 ∗ 2.6∗ 2.6∗ 43 ∗ 2.6∗ 2.6∗
Abdominal tone 4 3.3∗ 2.6∗ 2.4∗ 43 ∗ 2.6∗ 2.4∗ 42 . 8 ∗ 2.2∗ 2∗ 42 . 8 ∗ 2.2∗ 2∗
Limb tone 4 3.6∗ 3.3∗ 3∗ 43 . 6 ∗ 3∗ 3∗ 43 . 6 ∗ 3∗ 3∗ 43 . 6 ∗ 3∗ 3∗
Grip strength 4 3.4∗ 2.8∗ 2.4∗ 43 . 4 ∗ 2.6∗ 2.4∗ 43 . 4 ∗ 2.6∗ 2.2∗ 43 . 4 ∗ 2.6∗ 2.2∗
Wire manoeuvre 0 0.5∗ 0.7∗ 1.2∗ 00 . 6 ∗ 0.9∗ 1.2∗ 00 . 7 ∗ 0.9∗ 1.2∗ 40 . 70 . 9 ∗ 1.2∗
(2) Equilibrium and gait
Righting reﬂects 0 0.2∗ 0.3∗ 0.5∗ 00 . 5 ∗ 0.6∗ 0.8∗ 00 . 5 ∗ 0.6∗ 0.80.1∗ 00 . 5 ∗ 0.7∗ 0.8∗
Hypotonic gait 0 0.4∗ 0.7∗ 0.8∗ 00 . 6 ∗ 0.8∗ 0.8∗ 00 . 6 ∗ 0.8∗ 00 . 6 ∗ 0.9∗ 1∗
(3) CNS excitation
T r e m o r s 0 000 0 000 0 00 00 000
T w i t c h e s 0 000 0 000 0 00 00 000
C o n v u l s i o n s 0 000 0 000 0 00 00 000
Autonomic
(1) Eyes: Palpebral closure 0 0 0.4∗ 0.6∗ 00 . 4 ∗ 0.5∗ 0.6∗ 00 . 4 ∗ 0.5∗ 0.6∗ 00 . 4 ∗ 0.5∗ 0.6∗
(2) Secretion Excitation
D i a r r h o e a +++ +++
(3) General
P i l o e r e c t i o n 0 000 0 000 0 00 00 000
H y p o t h e r m i a +++ ++ + +++
Respiratory rate 4 3.8∗ 3.6∗ 3.4∗ 43 . 8 ∗ 3.6∗ 3.4∗ 43 . 8 ∗ 3.6∗ 3.4∗ 43 . 8 ∗ 3.6∗ 3.4∗
S k i n c o l o u r 4 444 4 444 4 44 44 444
(a) C, control, 10, 20, and 40mg/Kg elenine. ∗P<. 05 versus control group.
Table 2: number of animals with loss of spontaneous movement, loss of muscle tone, and loss of righting reﬂex against the number of
observations before and after 1, 2, and 3h of treatment.
Loss of spontaneous movement Loss of muscle tone Loss of righting reﬂex
Treatment(a) C E-10 E-20 E-40 CHL C E-10 E-20 E-40 CHL C E-10 E-20 E-40 CHL
Before 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10 0/10
1h 0/10 3/10∗ 6/10∗ 7/10∗ 8/10∗ 0/10 3/10∗ 4/10∗ 6/10∗ 7/10∗ 0/10 0/10 1/10 3/10∗ 3/10∗
2h 0/10 4/10∗ 7/10∗ 8/10∗ 9/10∗ 0/10 4/10∗ 6/10∗ 7/10∗ 8/10∗ 0/10 0/10 1/10 3/10∗ 3/10∗
3h 0/10 4/10∗ 7/10∗ 8/10∗ 9/10∗ 0/10 6/10∗ 6/10∗ 7/10∗ 8/10∗ 0/10 0/10 1/10 3/10∗ 3/10∗
(a) C, control, 10, 20, and 40mg/Kg elenine; CHL, chlorpromazine 10g/Kg. ∗P<. 05 versus control group.6 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Eﬀect of elenine 10, 20, and 40mg/kg and chlorpro-
mazine 10mg/kg on muscular relaxant activity. The data represent
themean ±SEMofthepermanencetime(sec.)onthestainlesssteel
wire at 30 and 60min. ∗P<. 05 versus control group.
and60min.Elenineproducedareductioninthepermanence
time with doses of 10mg/kg (P<. 05), 20mg/kg (P<. 05),
40mg/kg (P<. 05) and chlorpromazine, 10mg/kg (P<. 05)
at 30min. compared with the control group. Similar results
were obtained at 60min. when 10mg/kg elenine (P<. 05),
20mg/kg (P<. 05) and 40mg/kg elenine (P<. 05) and
chlorpromazine, 10mg/kg (P<. 05) were compared with
the control. No statistical diﬀerences between elenine (20
and 40mg/Kg) and chlorpromazine (10mg/Kg) at 30 and
60min. were observed.
3.6.LocomotorActivity. Figure 3shows thenumberofcounts
during the ﬁrst 60min after administration of vehicle
(control), elenine 10, 20 and 40mg/kg or chlorpromazine,
10mg/kg i.p. The spontaneous activity was lower after
administration of elenine to doses of 10mg/kg (P<. 05),
20mg/kg(P<. 05),40mg/Kg(P<. 05)and chlorpromazine,
10mg/kg i.p (P<. 05) compared with the control. Statistical
diﬀerences between three doses of elenine (10, 20, and
40mg/Kg) were observed. No statistical diﬀerences between
elenine (40mg/Kg) and chlorpromazine (10mg/Kg) were
observed.
3.7. Open-Field Test. Figure 4 shows that, in the open-ﬁeld,
elenine at doses of 10, 20, and 40mg/kg and chlorpromazine
10mg/Kg produced a decrease in the number of squares
compared with the control group (P<. 05). No statistical
diﬀerences between elenine (40mg/Kg) and chlorpromazine
10mg/Kg were observed. Chlorpromazine decreased the
number of squares in open-ﬁeld test with respect to control
(P<. 05) and doses of 10 (P<. 05), 20 (P<. 05) and
40mg/kg (P<. 05) of elenine.
Areductioninrearingscores(Figure 5)atdosesof10,20,
and40mg/kgcomparedwiththecontrolgroupwasobtained
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Figure 3: Eﬀect of elenine 10, 20, and 40mg/kg and chlorpro-
mazine 10mg/kg on locomotor activity. The data represent the
mean ± SEM of number counts during 60min. ∗P<. 05 versus
control group.
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Figure 4: Eﬀect of elenine 10, 20, and 40mg/kg and chlorpro-
mazine 10mg/kg on open-ﬁeld test: number of squares crossed for
5min. The data represent the mean ± SEM. ∗P<. 05 versus control
group.
and statistical diﬀerences between three doses of elenine
were observed. Chlorpromazine produced a reduction in the
number of rearings in the open-ﬁeld test in comparison with
the control group (P<. 05), 10 and 20mg/kg (P<. 05) of
elenine, respectively.
An increase in the number of faecal boluses (Figure 6)
with 10 (P<. 05), 20 (P<. 05) and 40mg/kg (P<
.05) of elenine compared with the control group was
o b s e r v e d .N os t a t i s t i c a ld i ﬀerences between the control and
chlorpromazine group were observed.Evidence-Based Complementary and Alternative Medicine 7
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Figure 5: Eﬀect of elenine 10, 20, and 40mg/kg and chlorpro-
mazine 10mg/kg on open-ﬁeld test: rearing patterns for 5min. The
data represent the mean ± SEM. ∗P<. 05 versus control group.
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Figure 6: Eﬀect of elenine 10, 20, and 40mg/kg and chlorpro-
mazine 10mg/kg on open-ﬁeld test: boluses for 5min. The data
represent the mean ± SEM. ∗P<. 05 versus control group.
3.8.MeasurementofBloodPressure. Thediastolicandsystolic
pressureofelenineisdepictedinFigures7and8,respectively.
Elenine at doses of 10 and 20mg/kg did not cause signiﬁcant
changesinsystolicpressureat30,60,and120minutesrespect
to basal. Elenine at the dose of 40mg/kg only caused a slight
decrease in the systolic pressure at 60, and 120 minutes. No
statistical diﬀerences among the three doses of elenine were
observed (Figure 7). Elenine at doses of 10, 20, and 40mg/kg
did not cause signiﬁcant changes in the diastolic pressure at
30,60,and120minutesrespecttobasal(Figure 8).Moreover,
elenine at doses of 10, 20, and 40mg/kg produced a decrease
in the pulse rate (beats/min) at 30, 60, and 120 minutes
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Figure 7:Eﬀect ofelenine10,20,and40mg/kgon SystolicPressure
(SPmm).The data represent the mean ± SEM for5rats at0,30,60,
and 120min.
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Figure 8: Eﬀect of elenine 10, 20, and 40mg/kg on Diastolic
Pressure (DP mm). The data represent the mean ± SEM for 5 rats
at 0, 30, 60, and 120min.
respect to basal. No statistical diﬀerences among the three
doses of elenine were observed (Figure 9).
4.Discussion
Elenine showed a moderate toxicity order in mice
(254mg/Kg). No lethality was observed for 7 days following
administration of elenine. Besides elenoside, its β-D
glucoside also showed moderate toxicity (305mg/Kg) [12].
This ﬁnding may explain the use of extracts of Justicia
hyssopifolia in popular medicine in the Canary Islands
[1, 2]. Furthermore, several Justicia plant species extracts
have been used (J. prostate, J. simplex, and J. Pectoralis)8 Evidence-Based Complementary and Alternative Medicine
Elenine 10mg/kg
Elenine 20mg/kg
Elenine 40mg/kg
03 0 6 0 9 0 120 150
300
350
400
B
e
a
s
t
(
m
i
n
u
t
e
)
Figure 9: Eﬀect of elenine 10, 20, and 40mg/kg on heart rate
(beats/min). The data represent the mean ± SEM for 5 rats at 0,
30, 60, and 120min.
in popular medicine [4, 5, 21]. Furthermore, Justicia
pectoralis, originally from tropical America, is used in folk
medicine for treating diseases such as treating pulmonary
infections or used as an ingredient in hallucinogenic snuﬀ
[21].
The eﬀect of elenine was investigated on certain other
characteristic actions of general observable behaviour. Thus,
nervous activity, observed by the spontaneous movements
of mice, gradually decreased 30min after intraperitoneal
injection of elenine. Motor-aﬀective responses in part reﬂect
the eﬀect of elenine on social behaviour. Sensorimotor-
responses reﬂect the capacity of the organism to respond
to environmental stimulation. The reduction of motor
aﬀective sensorimotor responses indicates an action similar
to drugs such as major tranquilizers, sedative hypnotics and
narcotics analgesics. Similar results at 25 and 50mg/Kg of
elenoside have been obtained [10]. Muscle tone decreased
after 30min following intraperitoneal injection of elenine
and this reduction continued for about 180min. The loss
of righting reﬂex and hypotonic gait, although slight, was
also evident 30min after administration. The results suggest
that the action of elenine is similar to the sedative action of
barbiturates and elenoside [10].
Hypothermia in mice was observed in a subjective
manner (by manual touch) by comparison between the
temperature of control animals and animals treated with
elenine (10, 20, and 40mg/kg) to 30, 60, 120, and 180min.
The parameter temperature was measured qualitatively. This
is the reason why (+) is used as the score. This manner of
scoring using Irwin tests is described by Gerad Vogel [22].
Also, Morales et al. [23] performed the Irwin test on some
diﬀerent extracts of the aerial parts, leaves, bark, and root
of plants showing higher activity and a decrease in motor
activity,backtonus,reversiblepalpebraltopsis,catalepsy,and
strong hypothermia. Moscardo et al. [24]u s i n gt h eI r w i n
test showed that the reference compounds (chlorpromazine,
diazepam and clonidine) induced hypothermia.
Central nervous activity in rats was examined in the
present work using established methods to test the basic
function of the CNS. Actions of psychopharmacological
agents for example, muscular relaxant activity, locomotor
activity and exploratory behaviour pattern were compared
with chlorpromazine. In the test concerning the muscular
relaxant activity, elenine was found to produce a loss of
muscular tone in the traction test in the doses given.
Muscular weakness due to elenine was dose dependent and
the duration of clinging on the wire net was a few seconds.
Elenine and chlorpromazine, 30min after administration,
produced an almost total inhibition of traction performance
when a dose of 10, 20, and 40mg/kg was given. This
eﬀect is well known for chlorpromazine [25, 26]a n dh a s
also been observed with lignans from Justicia pectoralis
[21]. These results are in accordance with those obtained
by Kuribara et al. [27], so that the test can be used to
distinguish between aprimary muscularrelaxant (diazepam)
a primary neuroleptic (chlorpromazine) and a more general
central depressant (pentobarbital)activity. Elenine produced
a signiﬁcant decrease in spontaneous locomotor activity in
rats when the Varimex test was used. A reduction in the
number of counts with two doses of elenine was observed.
This eﬀect has also been shown with lignans from Virola
elongata bark [28], etoposide [6] and elenoside [13].
Varimex and open-ﬁeld were performed as these are
complementary tests. Both tests look at the same parameter.
Moreover, the open-ﬁeld test is used as an animal model of
emotional behaviour. Animals with higher levels of motor
activity and lower boli rates have been taken to indicate
that they exhibit less emotionality, anxiety, fearfulness
[29]. Some authors suggest that the open-ﬁeld test shows
aspects of many types of behaviour including exploration,
locomotor activity and anxiety [30, 31]. Also, Moscardo
showed that reference compounds induced their typical and
expected transient eﬀects on neurobehaviour, observed both
in the home cage and open-ﬁeld and on body temperature.
Thus, chlorpromazine, diazepam and clonidine induced
depressive, anxiolytic or sedative eﬀects associated with
hypothermia [24].
These results agree with those obtained by the Irwin
test, [10, 12] on general behaviour, and a depression of
locomotor activity is common to most neuroleptics [25].
Elenine produced a signiﬁcant decrease in the exploratory
behaviour pattern, as can be seen from the results of the
open-ﬁeld test. Reduction of exploratory behaviour (squares
and rearing) after treatment with elenine is similar to the
actions of many other tranquilizer drugs [32] and elenoside
[13]. The increase in the number of boluses and reﬂex
of emotional behaviour in the open-ﬁeld test could be
responsible for the cathartic action, obtained with 10, 20,
and 40mg/kg of elenine, characteristic of elenoside [13]a n d
other antineoplastic compounds [8].
Besides which, because there is a structural anal-
ogy between arylnaphthalene lignans and digitalis, cardiac
parameters such as blood pressure and heart rate were
monitored. Thus, elenine did not cause signiﬁcant changesEvidence-Based Complementary and Alternative Medicine 9
in systolic and diastolic pressure at doses of 10, 20, and
40mg/kg. However, elenine produced a slight decrease in the
pulse rate (beats/min). Similar eﬀects have been obtained
with cardiac glucosides but of greater amplitude [33].
Moreover, there are no ﬁndings with respect to a possible
modulationofexcitatory/inhibitoryneurotransmitter release
in the CNS by arylnaphthalene lignans. However, some
studies have been reported with other types of lignans.
Zhang and Niu [34] have found that schizandrol (Schizandra
lignan) exerts inhibitory eﬀects on the central nervous
system. For the purpose of elucidating the mechanism of
inhibition, the concentration of monoamine neurotransmit-
ters and metabolites in the rat brain as well as the eﬀects
of schizandrol A on some receptors were determined by
the ion-pairing reversed-phase liquid chromatography with
electrochemical detection method and comparative binding
assay. In the neurotransmitter studies, signiﬁcant elevations
of dopamine and its metabolite (DOPAC) (in striatum)
and DA (in hypothalamus) were observed after i.p. admin-
istration of 50mg/kg or 100mg/kg of schizandrol A, but
the receptor binding experiments showed that schizandrol
Ah a dn oa ﬃnity for dopamine D1 and D2 receptors.
Serotoninreceptorsandα-1,α-2 adrenergic receptorsdid not
aﬀect the binding of dopamine D1 and D2 receptors. These
results indicate that the inhibition exerted by schizandrol
A on the CNS may be related to the dopamine system
and the increase of dopamine turnover has nothing to do
with dopamine receptors. Furthermore, Valerian oﬃcinalis
is used in the traditional medicine of many cultures as a
mild sedative and tranquilizer or as an aid to induce sleep.
The major constituents include monoterpene bornyl acetate,
sequiterpene valerenic acid, and other types of sesquiterpene
and lignans. Some of these constituents have been shown to
haveadirectaction ontheamygdaloid bodyofthebrain,and
valerenic acid has been shown to inhibit enzyme-induced
breakdown of GABA in the brain resulting in sedation.
Another ﬁnding of the lignan hydroxyl pinoresinol shows its
ability to bind benzodiazepine receptors [35].
Moreover, arylnaphtalene lignans could be involved
in several phenomena in the brain of rat, and further
studies are necessary to elucidate the mechanism of excita-
tory/inhibitory neurotransmitters release in the CNS.
On the basis of the above ﬁndings of the present
investigation, it can be concluded that elenine has a CNS-
depressant action, mostly similar to that of elenoside and
other psychopharmacological agents but with lower doses
than those used with elenoside. This study supports the
central sedative and relaxant properties of elenine and its
possible application in anxiety conditions. The sedative
properties of this lignan might be relevant to its future
therapeutic application.
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